M

Melior Discovery

31 employees

Melior Discovery offers a pharmacology platform to identify novel indications for pre-clinical development stage drug candidates.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
In vivo pharmacology
Pharmaceutical
Parkinson's Disease
in vivo models of efficacy
drug repositioning
drug reprofiling
drug repurposing
multiplexing
rodent models of disease
theraTRACE
phenotypic screening
behavioral assays
Biopharma
diabetes

Date founded

2005

Funding rounds raised

Total raised

$2.5M

from 6 investors over 6 rounds

M

Melior Discovery raised undisclosed on June 20, 2012

Investors: BioAdvance

M

Melior Discovery raised undisclosed on December 14, 2011

Investors: BioAdvance

M

Melior Discovery raised undisclosed on April 21, 2010

Investors: BioAdvance

M

Melior Discovery raised undisclosed on June 11, 2007

Investors: BioAdvance

M

Melior Discovery raised $2.5M on April 5, 2006

Investors: Osage Partners

M

Melior Discovery raised $500K on January 25, 2005

Investors: BioAdvance

FAQ